ENTITY
Sumitomo Pharma

Sumitomo Pharma (4506 JP)

135
Analysis
Health Care • Japan
Sumitomo Dainippon Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical products, as well as conducts clinical pathology tests for animals. Sumitomo Dainippon Pharma conducts businesses across worldwide.
more
•11 Nov 2018 18:54

Japan: Moving Average Outliers - Results Driven

MOVING AVERAGE OUTLIERS - Our moving average outlier indicator uses a weighted sum of the share price relative to the 5-day, 20-day, 60-day, 120...

Logo
565 Views
Share
bearish•Sumitomo Pharma
•30 Oct 2018 23:56

Sumitomo Dainippon 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Latuda grew 3.6% to ~¥90b in the US, however, an 8.8% decline in domestic sales to ~¥66b led the overall sales decline of 2.2% to...

bearish•Sumitomo Pharma
•27 Jun 2018 20:51

Current Market Price Discounts Favourable Outcome from Latuda’s Upcoming Binary Event

We reiterate our “Underweight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earningsNeither through recent launches, nor...

•06 Apr 2018 13:44

Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas

Takeda Pharmaceutical Co Ltd (4502 JP), Shionogi & Co Ltd (4507 JP), Nippon Shinyaku Co Ltd (4516 JP) , Sumitomo Dainippon Pharma Co (4506 JP),...

•29 Mar 2018 14:03

Japan Pharmaceutical - Sector Overview

Core coverage – relative valuations Takeda Pharmaceutical Co Ltd (4502 JP) (NB: Pre-Shire announcement | Pro-Forma analysis to be published...

x